YD Bio Ltd YDES
7.18 USD +0.23 (+3.31%)
At closeNov 6, 2026, 6:55 AM EST
7.20 +0.02 +0.28%
Pre-market · Nov 6, 6:55 AM ET
6.56 Day range 7.28
1.70 52-week range 15.72
- YTD
- -41.10%
- 1 year
- -23.70%
Financial health
Altman Z-Score
53.69 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 1
Valuation
P/E -102×
FY 2020 5y median 20.4× FY 2025
P/S 1363×
FY 2020 5y median 97.8× FY 2025
P/B -285×
FY 2020 5y median 7.6× FY 2025
P/FCF -101×
FY 2020 5y median -101× FY 2025
EV/EBITDA -99.6×
FY 2020 5y median 20.2× FY 2025
EV/Sales 1353×
FY 2020 5y median 91.7× FY 2025
FCF Yield -1.0%
FY 2020 5y median -1.0% FY 2025
Profitability
Gross Margin -7.1%
FY 2020 5y median 0.0% FY 2025
Operating Margin -883.3%
FY 2020 5y median -2.8% FY 2025
Net Margin -1392.6%
FY 2020 5y median 0.0% FY 2025
ROE 291.0%
FY 2020 5y median 33.8% FY 2025
ROIC -43.4%
FY 2020 5y median -18.8% FY 2025
ROA -60.3%
FY 2020 5y median 4.2% FY 2025
Growth (YoY)
Revenue 16.9%
FY 2020 FY 2025
Operating Income -260.6%
FY 2020 FY 2025
EPS (diluted) 78.6%
FY 2020 FY 2025
Free Cash Flow -69.3%
FY 2020 FY 2025
Financial Health
Current Ratio 5.9×
FY 2020 5y median 0.9× FY 2025
Quick Ratio 4.7×
FY 2020 5y median 0.7× FY 2025
Debt / Equity -0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2020 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31